Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing
Hamtandi Magloire Natama(Research Institute of Health Sciences), Anna Rosanas‐Urgell(Papua New Guinea Institute of Medical Research), Delwendé Florence Ouédraogo(Institut de Recherche en Sciences de la Santé), Pètra F. Mens(Amsterdam UMC Location University of Amsterdam), Luc Kestens(University of Antwerp), Hermann Sorgho(Institut de Recherche en Sciences de la Santé), Eduard Rovira-Vallbona(Instituut voor Tropische Geneeskunde), Maminata Coulibaly-Traoré(Institut de Recherche en Sciences de la Santé), Elisa Serra‐Casas(Instituut voor Tropische Geneeskunde), M. Athanase Somé(Institut de Recherche en Sciences de la Santé), Halidou Tinto(Institut de Recherche en Sciences de la Santé)
Cited by 36
Related Papers
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
|The Lancet|2021|457
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
|New England Journal of Medicine|2015|451
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
|The Lancet|2024|345